Comparison of nalbuphine and sufentanil for colonoscopy: A randomized controlled trial.
Chaoyi DengXiao WangQianmei ZhuYanming KangJinlin YangHeng WangPublished in: PloS one (2017)
Nalbuphine can be considered as a reasonable alternative to sufentanil in patients undergoing colonoscopy. Doses in the range of 0.1-0.2 mg/kg are recommended. The decreased risks of respiratory depression and apnea make nalbuphine suitable for patients with respiratory problems.